Published data supporting this possibility show that MT1-MMP is required for invadopodia-mediated matrix degradation [24], MT1-MMP is required for tumor cells to traverse collagen-rich ECM barriers [46], [48], [49], and invasion in collagen is sensitive to Src and protease inhibitors [50]. The gene discussed is SRC; the disease is neoplasm.